BID expression determines the apoptotic fate of cancer cells after abrogation of the spindle assembly checkpoint by AURKB or TTK inhibitors.
- DOI
- 10.1186/s12943-023-01815-w
- Published
- 2023 Jul 13
- Container
- Molecular cancer
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s12943-023-01815-w,
title = {BID expression determines the apoptotic fate of cancer cells after abrogation of the spindle assembly checkpoint by AURKB or TTK inhibitors.},
author = {Bertran-Alamillo J and Giménez-Capitán A and Román R and Talbot S and Whiteley R and Floc'h N and Martínez-Pérez E and Martin MJ and Smith PD and Sullivan I and Terp MG and Saeh J and Marino-Buslje C and Fabbri G and Guo G and Xu M and Tornador C and Aguilar-Hernández A and Reguart N and Ditzel HJ and Martínez-Bueno A and Nabau-Moretó N and Gascó A and Rosell R and Pease JE and Polanska UM and Travers J and Urosevic J and Molina-Vila MA},
year = {2023},
journal = {Molecular cancer},
doi = {10.1186/s12943-023-01815-w},
url = {https://doi.org/10.1186/s12943-023-01815-w}
}RIS
TY - JOUR TI - BID expression determines the apoptotic fate of cancer cells after abrogation of the spindle assembly checkpoint by AURKB or TTK inhibitors. AU - Bertran-Alamillo J AU - Giménez-Capitán A AU - Román R AU - Talbot S AU - Whiteley R AU - Floc'h N AU - Martínez-Pérez E AU - Martin MJ AU - Smith PD AU - Sullivan I AU - Terp MG AU - Saeh J AU - Marino-Buslje C AU - Fabbri G AU - Guo G AU - Xu M AU - Tornador C AU - Aguilar-Hernández A AU - Reguart N AU - Ditzel HJ AU - Martínez-Bueno A AU - Nabau-Moretó N AU - Gascó A AU - Rosell R AU - Pease JE AU - Polanska UM AU - Travers J AU - Urosevic J AU - Molina-Vila MA PY - 2023 JO - Molecular cancer DO - 10.1186/s12943-023-01815-w UR - https://doi.org/10.1186/s12943-023-01815-w ER -
APA
J, B., A, G., R, R., S, T., R, W., N, F., E, M., MJ, M., PD, S., I, S., MG, T., J, S., C, M., G, F., G, G., M, X., C, T., A, A., N, R., HJ, D., A, M., N, N., A, G., R, R., JE, P., UM, P., J, T., J, U., & MA, M. (2023). BID expression determines the apoptotic fate of cancer cells after abrogation of the spindle assembly checkpoint by AURKB or TTK inhibitors.. Molecular cancer. https://doi.org/10.1186/s12943-023-01815-w
Source records
- pubmed · retrieved 2026-09-26T22:41:11.567Z